Vijay Sikand

Right, and there are those cases.

One could write a chapter or two in a book about that.

I was making rounds in the hospital, and the nurse on the floor came up to me and said, Hey, Doc, there's a guy on the phone.

He says he's from a drug company.

He says he wants to talk to you.

I said, drug company?

Why is he calling me at the hospital?

I'm making rounds.

And she said, I don't know.

He says, can you talk to him?

I said, OK.

I went over to the nurse's station and I picked up the phone and there was a gentleman there on the phone.

His name was David Krauss.

He introduced himself and said, you know, we've developed a vaccine for Lyme disease that's now ready for phase three, which is the the actual late stage testing to see if it works.

It had only been through the early phases where you just check to see that it's actually sort of safe to give to animals.

Then you see if it's safe to give to people.

And then as it may be safe in a small number of people.

But you don't check to see if it actually works until you know all of those ducks are in order.

So anyway, so Dr. Krause said, would you be interested in working with us on this vaccine now that we've reached this stage?

And I said, well, that's fascinating, of course.